leadf
logo-loader
viewNanoveu Ltd

Nanoveu Ltd looking to have its antiviral smartphone protectors on sale 'within months'

Nanoveu Ltd’s (ASX:NVU) chairman and chief executive Alfred Chong discusses with Proactive's Andrew Scott their antiviral protective screens and cases for tablets and smartphones.

He says the nanotechnology incorporated within them has proven to be effective against viruses and bacteria such as influenza-A and E. coli and they're currently undergoing testing to see if they can protect against COVID-19.

The plan is to have them available and on sale around June/July this year.

Quick facts: Nanoveu Ltd

Price: 0.063 AUD

ASX:NVU
Market: ASX
Market Cap: $9.84 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Nanoveu Ltd named herein, including the promotion by the Company of Nanoveu Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Nanoveu focused on commercialising EyeFyx product following 'revolutionary'...

Nanoveu Ltd's (ASX:NVU) Alfred Chong caught up with Proactive's Andrew Scott after completing what they describe as a revolutionary advanced prototype of its EyeFyx product. It's designed to correct farsightedness for people using digital devices without the need for glasses. The company has...

on 18/11/20

2 min read